Fig. 1: Adjudicated mIWG–MRT–ECNM response by cycle.
Includes patients in the interim analysis efficacy population (n = 32). SD, stable disease; PD, progressive disease; NE, not evaluable.
Fig. 1: Adjudicated mIWG–MRT–ECNM response by cycle. | Nature Medicine
